Europe Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
The lymphedema treatment market in Europe is expected to grow from US$ 2,801.39 million in 2021 to US$ 3,953.12 million by 2028; it is estimated to grow at a CAGR of 5.0% from 2021 to 2028.
One report states that treatment plans are designed for determining the stages and causes of the condition. For example, surgeons performed several reconstructive surgical interventions, including vascularized lymph node transfer, lymphovenous bypass, and a type of liposuction for reducing swelling. Additionally, the non-surgical techniques include complete decongestive therapy (CDT). Several hospitals are equipped with beds that perform CDP on patients due to satisfactory medical coverage. New tests, coupled with technological advancements, play a critical role in controlling the prevalence of lymphedema cases among patients. On the other hand, the lymphedema management program provides services related to physical and occupational therapists that have been extensively trained in skilled treatment techniques for lymphedema management. One major company has developed a rehabilitation program based on therapists' training and working knowledge of current medical management of primary and secondary lymphedema with rehabilitative needs. Also, services by physical and occupational therapists are brought together for developing a personalized treatment plan for restoring the patient to the highest level of functioning. A major aim of such an innovative rehabilitation program is to educate and instruct patients about self-assist techniques for managing primary and secondary lymphedema independently. So, increasing healthcare services and lymphedema management programs is expected to fuel the market growth.Countries in the European regions were profoundly affected due to the COVID-19 pandemic. For instance, countries such as Italy, Spain, and France have reported the highest number of positive cases and have registered the maximum number of deaths. For instance, according to the Worldsometer, as of January 2022, 101,188,010 total cases, and 1,565,203 deaths have been registered due to COVID–19 in Europe. Countries across Europe are witnessing a resurgence in COVID-19 cases after successfully mitigating outbreaks early in the year. Many countries are declaring more cases each day now than during the first wave earlier last year. Lockdowns are being reintroduced in the UK, Spain, Italy, and Ireland, as per the European Centre for Disease Prevention and Control (ECDC). Due to the second wave of COVID-19 cases, many countries' government is working towards boosting up their treatments and regenerative medicines technologies for development of various diseases including COVID-19. Additionally, in the UK, the practice of cancer and neurological diseases has changed. Increasing COVID-19 has affected the diagnosis and treatment of diseases, due to the diversification of the medical workforce and decision to focus on treating the critically ill. Due to the current pandemic, many research organizations, are focusing more on COVID 19 studies and are working hard to better understand the virus. The lymphedema treatment market witnessed a shortfall at the beginning of the COVID-19 crisis due to disruption in the supply chain and slumped demand of medical devices (used for the treatment of lymphedema) due to the lockdown announced by most European countries that caused disruptions in manufacturing and operations in the sector. Additionally, appointments and operations have been delayed in many clinics around the world due to increasing cases, as approximately 40% of the diagnosed COVID-19 cases required hospitalisation; and some critical cases were admitted to intensive care units (ICU). According to an article in Vascular News, in the first week of the pandemic outbreak, there was an 80 percent reduction in beds and an 84 percent reduction in operating rooms for elective procedures, with 43 percent of hospitals in Italy not doing any elective surgery. With the number of rising cases, there was a significant decrease in procedures due to a lack of healthcare resources. It also impacted the new product launches, impacting sales and growth of the market in the region. However, with the implementation of proper guidelines and protocols by the European Commission to reduce SARS-CoV-2 exposure and ease in restrictions on movement, the market is expected to grow in the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the lymphedema treatment market. The Europe lymphedema treatment market is expected to grow at a good CAGR during the forecast period.
Europe Lymphedema Treatment Market Revenue and Forecast to 2028 (US$ Million)
Europe Lymphedema Treatment Market Segmentation
Europe Lymphedema Treatment Market – By Condition Type
- Primary Lymphedema
- Secondary Lymphedema
Europe Lymphedema Treatment Market – By Treatment Type
- Laser Therapy
- Compression Devices
- Drug Therapy
- Physiological Procedures
- Lymphovenous Anastomosis (LVA)
- Vascularised Lymph Node Transfer (VLNT)
- Debulking Procedures
- Surgical Debulking
- Liposuction
- Others
- Others
Europe Lymphedema Treatment Market – By End-User
- Hospitals
- Clinics
- Clinical Research Organizations
- Others
Europe Lymphedema Treatment Market- By Country
- U.K.
- Germany
- France
- Italy
- Spain
- Rest of Europe
Europe Lymphedema Treatment Market-Companies Mentioned
- 3M Company
- BSN medical GmbH
- Huntleigh Healthcare Limited
- Lohmann & Rauscher GmbH & Co. KG
- Mego Afek ltd
- Sigvaris Group
- Smith & Nephew
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Lymphedema Treatment Market – By Condition Type
1.3.2 Europe Lymphedema Treatment Market – By Treatment Type
1.3.3 Europe Lymphedema Treatment Market – By End-User
1.3.4 Europe Lymphedema Treatment Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Lymphedema Treatment Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Lymphedema Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Lymphedema Cases
5.1.2 Increasing Healthcare Services
5.2 Market Restraints
5.2.1 Lack of Awareness and Skilled Professionals
5.3 Market Opportunities
5.3.1 Rising Treatment Options
5.4 Future Trends
5.4.1 Use of Robotics for Lymphedema Treatment
5.5 Impact Analysis
6. Lymphedema Treatment Market– Europe Analysis
6.1 Europe Lymphedema Treatment Market Revenue Forecast and Analysis
7. Europe Lymphedema Treatment Market– By Condition Type
7.1 Overview
7.2 Europe Lymphedema Treatment Market, By Condition Type, 2021 & 2028 (%)
7.3 Primary Lymphedema
7.3.1 Overview
7.3.2 Primary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Secondary Lymphedema
7.4.1 Overview
7.4.2 Secondary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8. Europe Lymphedema Treatment Market – By Treatment Type
8.1 Overview
8.2 Europe Lymphedema Treatment Market, By Treatment Type, 2021 & 2028 (%)
8.3 Laser Therapy
8.3.1 Overview
8.3.2 Laser Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.4 Compression Devices and Bandaging
8.4.1 Overview
8.4.2 Compression Devices and Bandaging: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.5 Drug Therapy
8.5.1 Overview
8.5.2 Drug Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.6 Physiological Procedures
8.6.1 Overview
8.6.2 Physiological Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.6.2.1 Lymphovenous Anastomosis (LVA)
8.6.2.1.1 Overview
8.6.2.1.2 Lymphovenous Anastomosis (LVA): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.6.2.2 Vascularized Lymph Nodes Transfer (VLNT)
8.6.2.2.1 Overview
8.6.2.2.2 Vascularized Lymph Nodes Transfer (VLNT): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.7 Debulking Procedures
8.7.1 Overview
8.7.2 Debulking Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.7.2.1 Surgical Debulking
8.7.2.1.1 Overview
8.7.2.1.2 Surgical Debulking: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.7.2.2 Liposuction
8.7.2.2.1 Overview
8.7.2.2.2 Liposuction: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.7.2.3 Others
8.7.2.3.1 Overview
8.7.2.3.2 Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9. Europe Lymphedema Treatment Market – By End User
9.1 Overview
9.2 Europe Lymphedema Treatment Market, By End User, 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.5 Clinical Research Organization (CRO’s)
9.5.1 Overview
9.5.2 Clinical Research Organizations (CRO’s): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
10. Europe Lymphedema Treatment Market – By Country Analysis
10.1 Overview
10.1.1 Europe: Lymphedema Treatment Market, by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Germany: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Germany: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.4 Germany: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.4.1 Germany: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.4.2 Germany: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.5 Germany: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 France: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 France: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 France: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.4 France: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.4.1 France: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.4.2 France: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.5 France: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 UK: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UK: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 UK: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4 UK: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4.1 UK: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4.2 UK: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.5 UK: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4 Italy: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Italy: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.4 Italy: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.4.1 Italy: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.4.2 Italy: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.5 Italy: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5 Spain: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Spain: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.4 Spain: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.4.1 Spain: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.4.2 Spain: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.5 Spain: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6 Rest of Europe: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Europe: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.4 Rest of Europe: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.4.1 Rest of Europe: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.4.2 Rest of Europe: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.5 Rest of Europe: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Europe Lymphedema Treatment Market
11.1 Overview
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Smith & Nephew
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 BSN medical GmbH
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Lohmann & Rauscher GmbH & Co. KG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sigvaris Group
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Huntleigh Healthcare Limited
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 3M Company
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Mego Afek ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Lymphedema Treatment Market Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 7. France: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 11. France: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 12. UK: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. UK: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)
Table 14. UK: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 15. UK: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 16. UK: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)
Table 19. Italy: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 21. Italy: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 22. Spain: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. Spain: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)
Table 24. Spain: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 25. Spain: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 26. Spain: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 27. Rest of Europe: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. Rest of Europe: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)
Table 29. Rest of Europe: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 30. Rest of Europe: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 32. Organic Developments Done by Companies
Table 33. Inorganic Developments Done by Companies
Table 34. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Lymphedema Treatment Market Segmentation
Figure 2. Europe Lymphedema Treatment Market, By Country
Figure 3. Europe Lymphedema Treatment Market Overview
Figure 4. Condition Type Segment led the Market in 2021
Figure 5. Germany is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis of Drivers and Restraints for Europe Lymphedema Treatment Market
Figure 9. Europe Lymphedema Treatment Market –Forecast and Analysis to 2028
Figure 10. Europe Lymphedema Treatment Market, by Condition Type, 2021 & 2028 (%)
Figure 11. Europe Primary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Europe Secondary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Europe Lymphedema Treatment Market, by Treatment Type 2021 & 2028 (%)
Figure 14. Europe Laser Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Europe Compression Devices and Bandaging: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Europe Drug Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Europe Physiological Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Europe Lymphovenous Anastomosis (LVA): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Europe Vascularized Lymph Nodes Transfer (VLNT): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Europe Debulking Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Europe Surgical Debulking: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Europe Liposuction: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Europe Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Europe Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Europe Lymphedema Treatment Market, by End User, 2021 & 2028 (%)
Figure 26. Europe Hospitals: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Europe Clinics: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Europe Clinical Research Organizations (CRO’s): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Europe Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Europe: Lymphedema Treatment Market, by Key Country – Revenue (2021) (US$ Million)
Figure 31. Europe: Lymphedema Treatment Market, by Country, 2021 & 2028 (%)
Figure 32. Germany: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. France: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. UK: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Italy: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Spain: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Rest of Europe: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Impact of COVID-19 Pandemic in European Country Markets
- 3M Company
- BSN medical GmbH
- Huntleigh Healthcare Limited
- Lohmann & Rauscher GmbH & Co. KG
- Mego Afek ltd
- Sigvaris Group
- Smith & Nephew
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe lymphedema treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe lymphedema treatment market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the lymphedema treatment market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution